Maternal antibodies providing neural protection to the infants "hasn't been noted before and is very important for pathogens that infect newborns because there is often some kind of neurologic consequence that may impact their entire lives," added lead study author Yike Jiang, an M.D./Ph.D. student at the medical school.
The treatment involves removing immune system cells known as T cells from each patient and genetically modifying the cells in the laboratory to attack and kill leukemia cells. The genetically modified cells are then infused back into patients. It's also known as CAR-T cell therapy.